Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Lebanon Healthcare Journal.
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
August 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
September 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 |
Press releases published on June 26, 2025
Extendicare Announces Renewal of Normal Course Issuer Bid
GlobeNewswire
·
June 26, 2025
MARKHAM, Ontario, June 26, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that the Toronto Stock Exchange (the “TSX”) has approved the renewal of Extendicare’s normal course issuer bid (“NCIB”). Under …
Teva Releases Q2 2025 Aide Memoire
GlobeNewswire
·
June 26, 2025
TEL AVIV, Israel, June 26, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q2 2025 Aide Memoire is available on the “Investors” page on its website. Q2 2025 Aide Memoire Teva has prepared this …
Lifeward Announces Closing of $2.6 Million Public Offering
GlobeNewswire
·
June 26, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 26, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …
Basel Medical Obtains Waiver of Lock-Up for Potential Strategic Fund Raising
GlobeNewswire
·
June 26, 2025
Singapore, June 26, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), today announced that Cathay Securities, Inc., as the representative of the several underwriters of the Company’s initial public offering, has granted its …
Regeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025
GlobeNewswire
·
June 26, 2025
TARRYTOWN, N.Y., June 26, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2025 financial and operating results on Friday, August 1, 2025, before the U.S. financial markets open. …
Achieve Life Sciences Announces Proposed Underwritten Public Offering
GlobeNewswire
·
June 26, 2025
SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference
GlobeNewswire
·
June 26, 2025
WAYNE, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it will provide a …
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 26, 2025
VANCOUVER, British Columbia and BOSTON, June 26, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …
CorMedix Inc. Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
June 26, 2025
BERKELEY HEIGHTS, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it intends …
INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th
GlobeNewswire
·
June 26, 2025
Company to host a conference call to discuss results at 8:00am EDT on June 30, 2025 Boca Raton, Florida, June 26, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, will host a …
America's Blood Centers Honors HOSA-Future Health Professionals Lifesaving Impact at 2025 International Leadership Conference
GlobeNewswire
·
June 26, 2025
Washington, DC, June 26, 2025 (GLOBE NEWSWIRE) -- America’s Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60 percent of the nation’s blood supply, honored HOSA-Future Health Professionals chapters …
EVA Pharma and BioPharma Town - Qiantang District, Hangzhou Sign a Strategic Cooperation Agreement
GlobeNewswire
·
June 26, 2025
HANGZHOU, China and CAIRO, June 26, 2025 (GLOBE NEWSWIRE) -- EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle East and Africa, has signed a cooperation agreement with the Chaming Qiantang …
EVA制药与杭州市钱塘区签署战略合作协议
GlobeNewswire
·
June 26, 2025
杭州，开罗, June 27, 2025 (GLOBE NEWSWIRE) -- EVA制药公司，中东和非洲地区增长最快的医疗保健组织之一，与杭州美丽云城管理办公室（Chaming Qiantang Management Office）签署了一项合作协议，以加强其全球战略扩展，并致力于在中国的创新、本地化和全球合作。 EVA …
Ocular Therapeutix™ Unveils New Corporate Branding, Reflecting its Transformation to a Retina-Focused Company
GlobeNewswire
·
June 26, 2025
BEDFORD, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, announced the launch of its new corporate branding and website today, marking …
PetVivo Sets Fiscal Fourth Quarter 2025 Conference Call for Monday, June 30 at 5:00 p.m. ET
GlobeNewswire
·
June 26, 2025
MINNEAPOLIS, MN, US, June 26, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, will hold a conference call on …
Autism Spectrum Disorder Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 20+ Companies and 22+ Therapies | DelveInsight
GlobeNewswire
·
June 26, 2025
New York, USA, June 26, 2025 (GLOBE NEWSWIRE) -- Autism Spectrum Disorder Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 20+ Companies and 22+ Therapies | DelveInsight Autism Spectrum Disorder is defined as a group of developmental …
Global Medical Drones Market Gearing Up for Outstanding Expansion at a CAGR of ~17% by 2032 | DelveInsight
GlobeNewswire
·
June 26, 2025
New York, USA, June 26, 2025 (GLOBE NEWSWIRE) -- Global Medical Drones Market Gearing Up for Outstanding Expansion at a CAGR of ~17% by 2032 | DelveInsight Several key factors are fueling the rising demand for medical drones, creating a supportive …
Press release: Transparency Notification from Shareholders
GlobeNewswire
·
June 26, 2025
Transparency Notification from Shareholders Ghent, Belgium – 26 June 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and …
Iona University Announces New Master’s Degree in Healthcare Leadership & Innovation
GlobeNewswire
·
June 26, 2025
New Rochelle …
STENTiT Enrolls First Patient in Clinical Trial Evaluating a Novel Stent with Regenerative Properties to Support Limb Preservation
GlobeNewswire
·
June 26, 2025
www.stentit.com Watch the video Click the White paper STENTiT Enrolls First Patient in Clinical Trial Evaluating a Novel Stent with Regenerative Properties to Support Limb Preservation EINDHOVEN, The Netherlands – June 26, 2025 – STENTiT, a pioneering …